Apathy in patients with Alzheimer's disease is a cost-driving factor

被引：5

作者：

Kruse, Christopher ^{[1
]}

Maier, Franziska ^{[2
]}

Spottke, Annika ^{[3
,4
]}

Bach, Jan-Philipp ^{[5
]}

Bartels, Claudia ^{[6
]}

Buerger, Katharina ^{[7
,8
]}

Fellgiebel, Andreas ^{[9
]}

Fliessbach, Klaus ^{[3
]}

Frolich, Lutz ^{[10
]}

Hausner, Lucrezia ^{[11
]}

Hellmich, Martin ^{[11
]}

Kloppel, Stefan ^{[12
]}

Klostermann, Arne ^{[13
,14
]}

Kornhuber, Johannes ^{[15
]}

Laske, Christoph ^{[16
,17
,18
]}

Peters, Oliver ^{[13
,14
]}

Priller, Josef ^{[13
,19
,20
]}

Richter-Schmidinger, Tanja ^{[15
]}

Schneider, Anja ^{[3
,21
]}

Shah-Hosseini, Kija ^{[11
]}

Teipel, Stefan ^{[22
,23
]}

von Arnim, Christine A. F. ^{[24
]}

Wiltfang, Jens ^{[6
,25
]}

van der Wurp, Hendrik ^{[1
,26
]}

Dodel, Richard ^{[1
,5
]}

Jessen, Frank ^{[2
,3
,27
]}

机构：

[1] Univ Duisburg Essen, Ctr Translat Neurol & Behav Res, Dept Geriatr Med, Duisburg, Germany

[2] Univ Hosp Cologne, Med Fac, Dept Psychiat, Kerpener Str 62, D-50924 Cologne, Germany

[3] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany

[4] Univ Bonn, Dept Neurol, Bonn, Germany

[5] Philipps Univ Marburg, Dept Neurol, Marburg, Germany

[6] Georg August Univ, Univ Med Ctr Goettingen UMG, Dept Psychiat & Psychotherapy, Gottingen, Germany

[7] Ludwig Maximilians Univ LMU, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany

[8] German Ctr Neurodegenerat Dis DZNE, Munich, Germany

[9] Landeskrankenhaus AoR, Ctr Mental Hlth Old Age, Mainz, Germany

[10] Heidelberg Univ, Zent Inst Seel Gesundheit Mannheim, Dept Geriatr Psychiat, Mannheim, Germany

[11] Univ Cologne, Fac Med, Inst Med Stat & Computat Biol, Cologne, Germany

[12] Univ Bern, Univ Hosp Old Age Psychiat, Bern, Switzerland

[13] German Ctr Neurodegenerat Dis DZNE, Berlin, Germany

[14] Charite, Dept Psychiat, Berlin, Germany

[15] Friedrich Alexander Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Erlangen, Germany

[16] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany

[17] Univ Tubingen, Hertie Inst Clin Brain Res, Sect Dementia Res, Tubingen, Germany

[18] Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany

[19] Charite, Dept Neuropsychiat, Berlin, Germany

[20] Berlin Inst Hlth, Berlin, Germany

[21] Univ Bonn, Klin Neurodegenerat Erkrankungen & Gerontopsychia, Bonn, Germany

[22] German Ctr Neurodegenerat Dis DZNE, Rostock, Germany

[23] Univ Hosp Rostock, Dept Psychosomat Med, Rostock, Germany

[24] Ulm Univ Hosp, Dept Neurol, Ulm, Germany

[25] German Ctr Neurodegenerat Dis DZNE, Gottingen, Germany

[26] TU Dortmund Univ, Dept Stat, Dortmund, Germany

[27] Univ Cologne, Excellence Cluster Cellular Stress Responses Agin, Cologne, Germany

来源：

ALZHEIMERS & DEMENTIA | 2023年 / 19卷 / 07期

关键词：

Alzheimer's disease; apathy; cost of illness; dementia; economics; resource use; NEUROPSYCHIATRIC SYMPTOMS; DEMENTIA; CARE; PREVALENCE; INVENTORY; GERMANY; TRIALS; MODELS; SCALE;

D O I：

10.1002/alz.12915

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

BackgroundApathy is the most frequent neuropsychiatric symptom in patients with dementia of the Alzheimer's type (DAT). We analyzed the influence of apathy on the resource use of DAT patients and their caregivers. MethodsIncluded were baseline data of 107 DAT patients from a randomized clinical trial on apathy treatment. The Resource Utilization in Dementia (RUD) instrument assessed costs over a 1-month period prior to baseline. Cost predictors were determined via a least absolute shrinkage and selection operator (LASSO). ResultsOn average, total monthly costs were euro3070, of which euro2711 accounted for caregivers' and euro359 for patients' costs. An increase of one point in the Apathy Evaluation Scale resulted in a 4.1% increase in total costs. DiscussionApathy is a significant cost driving factor for total costs in mild to moderate DAT. Effective treatment of apathy might be associated with reduced overall costs in DAT.

引用

页码：2853 / 2864

页数：12

共 50 条

[31] AGOMELATINE FOR TREATING APATHY IN ALZHEIMER'S DISEASE
Karaiskos, D.
Pappa, D.
Katirtzoglou, E.
Siarkos, K.
Tzavellas, E.
Papadimitriou, G. N.
Politis, A.
EUROPEAN PSYCHIATRY, 2014, 29
[32] Noradrenergic therapies for apathy in Alzheimer's disease?
Husain, Masud
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2023, 94 (02): : 93 - 93
[33] Pharmacological interventions for apathy in Alzheimer's disease
Ruthirakuhan, Myuri T.
Herrmann, Nathan
Abraham, Eleenor H.
Chan, Sarah
Lanctot, Krista L.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (05):
[34] Therapy of the apathy syndrome in Alzheimer's disease
Fellgiebel, Andreas
Scheurich, Armin
ZEITSCHRIFT FUR PSYCHIATRIE PSYCHOLOGIE UND PSYCHOTHERAPIE, 2008, 56 (01): : 51 - 55
[35] Apathy and Attentional Biases in Alzheimer's Disease
Chau, Sarah A.
Chung, Jonathan
Herrmann, Nathan
Eizenman, Moshe
Lanctot, Krista L.
JOURNAL OF ALZHEIMERS DISEASE, 2016, 51 (03) : 837 - 846
[36] Neuropathologic correlates of apathy in Alzheimer's disease
Cummings, JL
Marshall, GA
Tekin, S
Fairbanks, L
Vinters, HV
NEUROLOGY, 2005, 64 (06) : A136 - A137
[37] Risk Factors for Apathy in Alzheimer's Disease
Hutchinson, K.
Dilks, L.
DuVall, T.
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2014, 29 (06)
[38] Structural correlates of apathy in Alzheimer's disease
Cummings, JL
Apostolova, LG
Akopyan, GG
Steiner, CA
Partiali, N
Toga, AW
Thompson, PM
NEUROLOGY, 2006, 66 (05) : A105 - A105
[39] CHALLENGES IN THE PHARMACOTHERAPY OF APATHY IN ALZHEIMER'S DISEASE
Lanctot, Krista
NEUROBIOLOGY OF AGING, 2014, 35 : S13 - S13
[40] Apathy and reward in Alzheimer's disease and MCI
Robert, P
Benoit, M
Michel, E
Ollivrin, N
Garcia, R
INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 90 - 91

← 1 2 3 4 5 →